Stock Fundamentals

Company Information

Company Name
Rxsight Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US78349D1072
CIK: 0001111485
CUSIP: 78349D107
Currency: USD
Full Time Employees: 461
Phone: 949 521 7830
Fiscal Year End: December
IPO Date: Jul 30, 2021
Description:

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Address:

100 Columbia, Aliso Viejo, CA, United States, 92656

Directors & Officers

Name Title Year Born
Dr. Ronald M. Kurtz M.D. President, CEO & Director 1963
Dr. Ilya Goldshleger Ph.D. Chief Operating Officer 1975
Mr. Eric J. Weinberg Chief Business Development Officer 1961
Mr. Mark Wilterding Chief Financial Officer NA
Mr. Oliver Moravcevic Vice President of Investor Relations NA
Mr. Jim Schindler Senior VP & General Counsel NA
Mr. Scott Gaines Chief Customer Officer NA
Ms. Maureen O'Connell Executive VP of Clinical & Regulatory Affairs NA
Mr. Patrick Cullen Executive VP of Quality & Infrastructure Operations NA
Mr. Adam Dashe Executive Vice President of International NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 2.70M Sep 30, 2025 6.55% $0.00 -10.12%
Vanguard Group Inc 2.23M Dec 31, 2025 5.40% $0.00 3.84%
Millennium Management LLC 2.19M Sep 30, 2025 5.31% $0.01 130.56%
Artisan Partners Limited Partnership 2.16M Dec 31, 2025 5.23% $0.03 23.01%
No Street GP LP 1.98M Dec 31, 2025 4.79% $1.39 21.54%
D. E. Shaw & Co LP 1.88M Dec 31, 2025 4.57% $0.01 2.72%
Citadel Advisors Llc 1.29M Sep 30, 2025 3.13% $0.00 25.52%
BNP Paribas Arbitrage, SA 975.74K Dec 31, 2025 2.36% $0.00 102.83%
Deutsche Bank AG 967.62K Sep 30, 2025 2.34% $0.00 -21.28%
Defilade Capital Management, L.P. 913.09K Dec 31, 2025 2.21% $1.29 0.00%
Morgan Stanley - Brokerage Accounts 844.65K Sep 30, 2025 2.05% $0.00 -15.68%
State Street Corp 824.14K Sep 30, 2025 2.00% $0.00 -10.05%
Two Sigma Investments LLC 798.36K Dec 31, 2025 1.93% $0.01 20.52%
Geode Capital Management, LLC 739.30K Sep 30, 2025 1.79% $0.00 -14.30%
UBS Group AG 735.17K Sep 30, 2025 1.78% $0.00 183.00%
Two Sigma Advisers, LLC 732.10K Dec 31, 2025 1.77% $0.01 0.26%
Bank of America Corp 722.44K Sep 30, 2025 1.75% $0.00 405.97%
Baillie Gifford & Co Limited. 693.15K Dec 31, 2025 1.68% $0.01 1.00%
Nuveen, LLC 531.73K Dec 31, 2025 1.29% $0.00 609.66%
Royal Bank of Canada 494.41K Sep 30, 2025 1.20% $0.00 -53.29%

Shares Statistics

Shares Outstanding: 41.27M
Shares Float: 36.93M
% Insiders: 564.00%
% Institutions: 9,004.10%
Short % Float: 14.06%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 BlackRock Inc 2.70M 6.55% ▼ 10.12% Sep 30, 2025
2 Vanguard Group Inc 2.23M 5.40% ▲ 3.84% Dec 31, 2025
3 Millennium Management LLC 2.19M 5.31% ▲ 130.56% Sep 30, 2025
4 Artisan Partners Limited Partnership 2.16M 5.23% ▲ 23.01% Dec 31, 2025
5 No Street GP LP 1.98M 4.79% ▲ 21.54% Dec 31, 2025
6 D. E. Shaw & Co LP 1.88M 4.57% ▲ 2.72% Dec 31, 2025
7 Citadel Advisors Llc 1.29M 3.13% ▲ 25.52% Sep 30, 2025
8 BNP Paribas Arbitrage, SA 975.74K 2.36% ▲ 102.83% Dec 31, 2025
9 Deutsche Bank AG 967.62K 2.34% ▼ 21.28% Sep 30, 2025
10 Defilade Capital Management, L.P. 913.09K 2.21% ▲ 0.00% Dec 31, 2025

Valuation Metrics

Enterprise Value: $84.98M
Trailing P/E: 0.00
Forward P/E: 116.28

Financial Highlights

Market Cap: $302.48M
EBITDA: $-44.93M
Book Value: $6.69
Earnings/Share: $-0.95
Profit Margin: -28.96%
Operating Margin: -34.77%
ROA (TTM): -9.56%
ROE (TTM): -13.98%
Revenue (TTM): $134.48M
Revenue/Share (TTM): $3.29
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -18.90%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 10.95x 0.00x 0.12x -1,204.75x -0.03x
2024-12-31 11.36x 0.00x 0.12x -1,755.14x -0.04x
2023-12-31 8.06x 0.01x 0.12x -15.14x -0.04x
2022-12-31 7.81x 0.47x 0.40x -12.80x -0.73x
2021-12-31 15.92x 0.33x 0.28x -14.34x -1.10x
2020-12-31 7.03x -0.09x 3.96x -69.42x 0.80x
2019-12-31 10.67x 0.00x 3.76x -1,771.92x 0.01x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 12, 2025 Tamara Fountain N/A Sale 7.00K $25.71 $179.97K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RXST.US!